Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
NCT ID: NCT06864689
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
EARLY_PHASE1
78 participants
INTERVENTIONAL
2026-01-31
2027-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South
NCT06487390
Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP
NCT05111119
Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM
NCT06661343
Increasing PrEP Awareness and Demand Among Black Cisgender Women
NCT05896423
Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence
NCT05530993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 1: A qualitative study using focus groups with Black women and key informant interviews with healthcare providers. (Will not be included in the clinical trial.)
Aim 2a: Pilot randomized controlled trial of a behavioral intervention with both Black women and healthcare providers.
Aim 2b: Social media marketing campaign to reach and engage Black women and healthcare providers in health communication about PrEP. (Will not be included in the clinical trial.)
The proposed research is significant because it will connect Black women to PrEP while increasing healthcare providers willingness to prescribe and refer PrEP to them using a health communication strategy that can guide the development of subsequent vlog-based interventions to address the national EHE plan.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Participants will watch a health-informed video-log series and complete a second survey (post-test). The post-test will assess the same variables previously assessed in the pre-test.
Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers
This intervention is a video-log (vlog) series based health communication intervention that will be disseminated through community health centers (CHCs) and social media to increase willingness for and use of PrEP among cisgender Black women and to increase willingness to prescribe and refer PrEP among healthcare providers.
Standard of Care
Participant will receive SOC and complete the post-test.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers
This intervention is a video-log (vlog) series based health communication intervention that will be disseminated through community health centers (CHCs) and social media to increase willingness for and use of PrEP among cisgender Black women and to increase willingness to prescribe and refer PrEP among healthcare providers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. be 18 years of age
3. have been sexually active with a man within the past 6 months
4. be fluent in English
5. have a phone or internet access
Eligible participants (i.e. PrEP-eligible BW) must not:
1. be unable to provide informed consent/assent for participation (i.e., have severe cognitive impairment hat would interfere with their ability to consent or understand study procedures)
2. have psychological distress that would prohibit them from participating in the study
3. be unable or unwilling to meet study requirements
4. be ineligible for PrEP
5. received a prescription for PrEP within 12 months6)be unable to fill out the evaluation independently
Eligible participants in the HCP category must:
1. be a credentialed HCP in Texas with privileges to prescribe and/or refer PrEP
2. BW must be a part of their patient pool at the clinical setting where they practice clinically
3. be fluent in English
4. have a phone or internet access
5. Live and/or practice medicine within a 60-mile radius of Houston/Harris County
Eligible HCP must not:
1. be unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent, or ability to understand study procedures
2. have psychological distress that would prohibit them from participating in the study
3. be unable or unwilling to meet study requirements
4. be unwilling to offer PrEP to BW patients
5. have prescribed or referred PrEP to BW within the last 12 months
18 Years
99 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
The University of Texas Medical Branch, Galveston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mandy Hill, DrPH,MPH,HIVPCP
Role: PRINCIPAL_INVESTIGATOR
University of Texas Medical Branch, Galveston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Medical Branch, Galveston
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mandy J. Hill, DrPH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-0363
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.